PR Novel Hematoma Prevention Device

Files

Authors

Nolan Shoukri, Oakland University William Beaumont School of Medicine Medical Student
Steven Pearl, Corewell Health East
Nishaki Mehta, Corewell Health East

Description

• Hematomas are a common complication in cardiac internal electronic device (CIED) placement procedures, they occur in up to 20-25% of CIED implants.

• Previous RCT tested a novel hematoma compression device (PR) and showed good tolerability, decreased hematoma formation from 15% to 6%, and wound improvement.

• Based on feedback collected from the nurses, physicians, allied health professionals during the randomized control trial, iteration of the PR was done (Gen 2 PR).

• This study evaluated 1) bench testing of the Gen 2 PR device and 2) healthy volunteer testing of Gen 2 PR device.

Publication Date

5-2025

Keywords

Hematomas, cardiac internal electronic device

Disciplines

Cardiology | Emergency Medicine

Recommended Citation

Shoukri N, Pearl S, Mehta N. PR novel hematoma prevention device. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2025 May; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2025.